Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2014-A00335-42 | Other Identifier | RCB number | |
| 2014-A00944-43 | Other Identifier | RCB number | |
| LOCAL/2014/AS-01 | Other Identifier | obsolete sponsor number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of this study is to evaluate the impact of a pharmaceutical consultation at the time of hospital discharge on the adherence of patients ; non-adherence is determined by the following criteria:
As concerns prescribed anti-infectious treatments, at least one of the following 4 criteria is true:
The secondary objectives of this study are :
A- To assess the percentage of patients who obtained their anti- infective pharmaceuticals
B- To evaluate the ratio of the number of units of anti- infective drugs dispensed by the pharmacy over the number of units of anti- infective drugs prescribed
C- To determine the ratio of the number of premature discontinuations of anti -infective treatments over the number of lines of anti -infective treatments prescribed
D- Evaluate the ratio of the number of units actually taken by the patient (based on a self-declaration) over the number of units of anti- infective drugs prescribed
E- To measure the comprehension concerning anti- infective treatments after returning home (based on a quiz)
F- To determine the risk factors for non- adherence to anti- infective therapy based on the characteristics of the study population
G- Assess patient satisfaction concerning a pharmaceutical consultation at hospital discharge (questionnaire)
H- Assess the impact of a pharmaceutical consultation on primary non-adherence (criteria 1 and 2) and secondary non- adherence (criteria 3 and 4)
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Routine care | Active Comparator | The patients in this receive routine care. Intervention: Routine care |
|
| Pharma consult | Experimental | The patients in this arm will have a pharmaceutical consult upon hospital discharge. Intervention: Pharma consult |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pharma consult | Other | Upon hospital discharge, patients randomized to the experimental arm will have a pharmaceutical consultation concerning their anti-infectious treatment. |
|
| Measure | Description | Time Frame |
|---|---|---|
| The presence/absence of treatment non-adherence | As concerns prescribed anti-infectious treatments, at least one of the following 4 criteria is true:
| 1 week after end of treatment (expected max of 4 weeks) |
| Measure | Description | Time Frame |
|---|---|---|
| Delivery of anti-infectious therapy by the pharmacy (yes/no) | 1 week after end of treatment (expected max of 4 weeks) | |
| Number of anti-infectious drug units dispensed by the pharmacy / number of anti-infections drug units prescribed | 1 week after end of treatment (expected max of 4 weeks) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Harmonie Faure | Centre Hospitalier Universitaire de Nīmes | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHRU de Nîmes - Hôpital Universitaire Carémeau | Nîmes | 30029 | France |
Not provided
| ID | Term |
|---|---|
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Routine care | Other | Patients randomized to this arm will receive care in the habitual manner. |
|
| Number of premature discontinuations of anti-infective therapies / the prescribed number of anti-infective treatments | 1 week after end of treatment (expected max of 4 weeks) |
| Number of anti-infectious drug units taken by the patient (self-declaration) / number of anti-infections drug units prescribed | 1 week after end of treatment (expected max of 4 weeks) |
| Quiz on anti-infective therapy comprehension | Day 0 (hospital discharge) |
| Socio-demographic characteristics | Day 0 (hospital discharge) |
| Test for measuring overall compliance (MAQ) | Day 0 (hospital discharge) |
| Satisfaction Questionnaire concerning pharmaceutical consultation | Day 0 (hospital discharge) |